https://www.guyanahealthreview.com/article/905898058-walking-yoga-app-how-combining-walking-and-yoga-accelerates-weight-loss Guyana Health Review en PressRelease 2026-04-15T13:33:30+00:00 Walking Yoga App: How Combining Walking and Yoga Accelerates Weight Loss https://ml-eu.globenewswire.com/media/27e0ac34-ddfe-42a2-8a0b-7469fbf18c71/medium/walking-yoga-a-new-method-to-lose-weight.png https://www.guyanahealthreview.com/article/905902021-avita-medical-founder-fiona-wood-honored-with-lifetime-achievement-award-by-american-burn-association Guyana Health Review en PressRelease 2026-04-15T13:20:00+00:00 AVITA Medical Founder Fiona Wood Honored with Lifetime Achievement Award by American Burn Association https://ml.globenewswire.com/media/53ad8139-952a-4470-9ede-2f3bf0521f16/small/avita-png.png https://www.guyanahealthreview.com/article/905901742-polaryx-therapeutics-recognized-with-pinnacle-award-for-excellence-in-pediatric-care Guyana Health Review en PressRelease 2026-04-15T13:15:00+00:00 Polaryx Therapeutics Recognized with Pinnacle Award for Excellence in Pediatric Care https://ml.globenewswire.com/media/64e2f507-40e8-46aa-b22e-6661e7035467/small/polaryx-logonew-png.png https://www.guyanahealthreview.com/article/905900906-pacbio-and-covaris-announce-joint-workflow-enabling-hifi-long-read-sequencing-of-ffpe-tumor-samples Guyana Health Review en PressRelease 2026-04-15T13:05:00+00:00 PacBio and Covaris Announce Joint Workflow Enabling HiFi Long-Read Sequencing of FFPE Tumor Samples https://ml.globenewswire.com/media/f408d681-e68c-4113-a7cd-be24486deefc/small/logo-centered-440x386-png.png https://www.guyanahealthreview.com/article/905901276-tango-therapeutics-announces-leadership-appointments-to-accelerate-late-stage-development-of-vopimetostat Guyana Health Review en PressRelease 2026-04-15T13:05:00+00:00 Tango Therapeutics Announces Leadership Appointments to Accelerate Late-Stage Development of Vopimetostat https://ml.globenewswire.com/media/d6e37a27-2e33-43bb-ae05-bfb0dedbf190/small/tango-logo-png.png https://www.guyanahealthreview.com/article/905897427-annual-general-meeting-of-kuros-biosciences-approves-all-resolutions Guyana Health Review en PressRelease 2026-04-15T13:00:00+00:00 Annual General Meeting of Kuros Biosciences approves all resolutions https://ml-eu.globenewswire.com/media/ad3777c9-af1f-4b09-a899-3b3d6b8e962d/small/kuros-logo-jpg.jpg https://www.guyanahealthreview.com/article/905898134-neuraclick-expands-scientific-and-translational-leadership-with-key-advisory-appointments Guyana Health Review en PressRelease 2026-04-15T13:00:00+00:00 NeuraClick Expands Scientific and Translational Leadership with Key Advisory Appointments https://ml.globenewswire.com/media/04731e85-f435-4ef9-9077-b81361bf43f9/small/neuraclick-png-png.png https://www.guyanahealthreview.com/article/905901024-dogwood-therapeutics-announces-fda-acceptance-of-sp16-investigational-new-drug-application-for-the-treatment-of-chemotherapy-induced-pain-and Guyana Health Review en PressRelease 2026-04-15T13:00:00+00:00 Dogwood Therapeutics Announces FDA Acceptance of SP16 Investigational New Drug Application for the Treatment of Chemotherapy Induced Pain and Neuropathy https://ml.globenewswire.com/media/7fe5cc47-6599-477c-a858-0f0d9b9f7eb5/small/green-and-gray-png.png https://www.guyanahealthreview.com/article/905898276-just-salad-expands-in-washington-d-c Guyana Health Review en PressRelease 2026-04-15T12:57:00+00:00 Just Salad Expands in Washington, D.C. https://ml.globenewswire.com/media/c9572eec-3547-4c38-987c-8a46d1b438f5/medium/interior-mural-at-1919-pennsylvania-avenue-nw.jpg https://www.guyanahealthreview.com/article/905901148-pds-biotech-announces-publication-of-positive-pds01adc-interim-phase-2-clinical-trial-data-from-stage-1-of-nci-led-metastatic-colorectal-cancer-mcrc Guyana Health Review en PressRelease 2026-04-15T12:45:00+00:00 PDS Biotech Announces Publication of Positive PDS01ADC Interim Phase 2 Clinical Trial Data from Stage 1 of NCI-led Metastatic Colorectal Cancer (mCRC) Trial https://ml.globenewswire.com/media/e2e7d124-dbd4-4140-9cc5-449d3488a902/small/pds-biotech-logo-png.png https://www.guyanahealthreview.com/article/905899926-biosyent-to-present-at-2026-bloom-burton-co-healthcare-investor-conference Guyana Health Review en PressRelease 2026-04-15T12:40:00+00:00 BioSyent to Present at 2026 Bloom Burton & Co. Healthcare Investor Conference https://ml.globenewswire.com/media/3dded277-7953-4418-be63-7d7a3067811d/small/biosyent-logo-png.png https://www.guyanahealthreview.com/article/905900740-inteleos-foundation-announces-2026-medmissions-award-to-advance-maternal-health-ultrasound-access-in-five-nations Guyana Health Review en PressRelease 2026-04-15T12:38:00+00:00 Inteleos Foundation Announces 2026 MedMissions Award to Advance Maternal Health Ultrasound Access in Five Nations https://ml.globenewswire.com/media/MGI2ZWI4MGItOTIzNi00ZGFlLWIxNzAtNmI5MjJjOGZkNjA1LTEyNDUwMzItMjAyNi0wNC0xNS1lbg==/tiny/Inteleos-Inc-.png https://www.guyanahealthreview.com/article/905898201-inspire-named-webby-awards-honoree-for-excellence-in-websites-mobile-sites-community Guyana Health Review en PressRelease 2026-04-15T12:35:00+00:00 Inspire Named Webby Awards Honoree for Excellence in Websites & Mobile Sites - Community https://ml.globenewswire.com/media/ODg2MTE3YjktZWY4Yy00Y2U2LWI0MWUtYmY5MjYxYjQ2MWRlLTUwMDEyOTE4NC0yMDI2LTA0LTE1LWVu/tiny/Inspire.png https://www.guyanahealthreview.com/article/905897330-healport-raises-1-2m-usd-to-scale-global-digital-health-infrastructure Guyana Health Review en PressRelease 2026-04-15T12:30:00+00:00 HealPort Raises 1.2M USD to Scale Global Digital Health Infrastructure https://ml-eu.globenewswire.com/media/d6eb6ad3-be4e-40b6-944e-9fac4d976b1e/small/img-20251206-wa0000-jpg.jpg https://www.guyanahealthreview.com/article/905898355-xenon-to-present-at-upcoming-investor-conferences Guyana Health Review en PressRelease 2026-04-15T12:30:00+00:00 Xenon to Present at Upcoming Investor Conferences https://ml.globenewswire.com/media/505b89d3-dfd1-46e8-bc3b-3c9c699ef7ec/small/xenon-logo-tm-full-color-250x80px-png.png https://www.guyanahealthreview.com/article/905901283-allogene-therapeutics-announces-nature-communications-publication-highlighting-pre-clinical-data-for-allo-329-a-next-generation-dual-targeted Guyana Health Review en PressRelease 2026-04-15T12:30:00+00:00 Allogene Therapeutics Announces Nature Communications Publication Highlighting Pre-Clinical Data for ALLO-329, a Next Generation Dual-Targeted CD19/CD70 Allogeneic CAR T for Autoimmune Diseases https://ml.globenewswire.com/media/87e8712c-0741-409f-9942-c91b31e7c5e1/small/allogene-png.png https://www.guyanahealthreview.com/article/905899913-purchaser-business-group-on-health-unveils-results-of-2026-annual-member-survey-of-america-s-largest-employers Guyana Health Review en PressRelease 2026-04-15T12:20:00+00:00 Purchaser Business Group on Health Unveils Results of ‘2026 Annual Member Survey’ of America’s Largest Employers https://ml.globenewswire.com/media/ZWE0Yjc4YjItYmYwNS00ZWVlLTllMjQtZDVjZjYwYjZmMmNkLTEyMTgzNzctMjAyNi0wNC0xNS1lbg==/tiny/Purchaser-Business-Group-on-He.png https://www.guyanahealthreview.com/article/905902991-traws-pharma-announces-up-to-60-million-private-placement-financing Guyana Health Review en PressRelease 2026-04-15T12:15:00+00:00 Traws Pharma Announces Up to $60 Million Private Placement Financing https://ml.globenewswire.com/media/1eb1780a-724e-4555-ab4d-455e27d18544/small/traws-pharma-blue-png.png https://www.guyanahealthreview.com/article/905898273-billiontoone-to-report-first-quarter-2026-financial-results-on-may-6-2026 Guyana Health Review en PressRelease 2026-04-15T12:05:00+00:00 BillionToOne to Report First Quarter 2026 Financial Results on May 6, 2026 https://ml.globenewswire.com/media/888ae54a-648f-4986-998b-84df416858c7/small/billion-to-one-logo-new-jpg.jpg https://www.guyanahealthreview.com/article/905902765-scienture-granted-180-day-extension-by-nasdaq-to-regain-compliance-with-minimum-bid-price-requirement Guyana Health Review en PressRelease 2026-04-15T12:05:00+00:00 Scienture Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement https://ml.globenewswire.com/media/56382978-c242-4bdd-b491-e6966e27d4ed/small/logo-png.png https://www.guyanahealthreview.com/article/905897683-ardena-opens-new-bioanalytical-laboratory-in-somerset-new-jersey Guyana Health Review en PressRelease 2026-04-15T12:02:10+00:00 Ardena Opens New Bioanalytical Laboratory in Somerset, New Jersey https://ml-eu.globenewswire.com/media/cf6817f0-2603-46b6-aa6b-1cbb814079c4/medium/ardena-u-s-facility-in-somerset-new-jersey.png https://www.guyanahealthreview.com/article/905898212-60-degrees-pharma-announces-arakoda-tafenoquine-for-malaria-prevention-is-now-available-on-runway-health-travel-website Guyana Health Review en PressRelease 2026-04-15T12:02:00+00:00 60 Degrees Pharma Announces ARAKODA (tafenoquine) for Malaria Prevention is Now Available on Runway Health Travel Website https://ml.globenewswire.com/media/c950cab5-27b1-476f-befc-4d92a7389fdd/small/60degrees-logo-rgb-logo-jpg.jpg https://www.guyanahealthreview.com/article/905897020-teva-launches-home-ground-schizophrenia-community-a-new-online-resource-hub-for-people-living-with-schizophrenia-and-their-care-partners Guyana Health Review en PressRelease 2026-04-15T12:00:00+00:00 Teva Launches Home Ground™ Schizophrenia Community, a New Online Resource Hub for People Living with Schizophrenia and Their Care Partners https://ml-eu.globenewswire.com/media/c2001734-949b-4cc2-8021-b4b64eda1f13/small/teva-rgb-jpeg-jpg.jpg https://www.guyanahealthreview.com/article/905897206-boehringer-ingelheim-and-zai-lab-announce-collaboration-on-dll3-targeting-t-cell-engager-and-adc-combination-in-small-cell-lung-cancer-and-other Guyana Health Review en PressRelease 2026-04-15T12:00:00+00:00 Boehringer Ingelheim and Zai Lab announce Collaboration on DLL3‑targeting T‑Cell Engager and ADC Combination in Small Cell Lung Cancer and Other Neuroendocrine Carcinomas https://ml-eu.globenewswire.com/media/f121dfae-77e7-4a01-b1ef-6b757767ddab/small/111boehringer-ingelheim-logo-rgb-dark-green-002-png.png https://www.guyanahealthreview.com/article/905897922-folia-health-launches-brave-pws-study-to-better-understand-the-real-world-experience-of-prader-willi-syndrome-caregivers Guyana Health Review en PressRelease 2026-04-15T12:00:00+00:00 Folia Health Launches “BRAVE-PWS” Study to Better Understand the Real-World Experience of Prader-Willi Syndrome Caregivers https://ml.globenewswire.com/media/858e11f4-96a0-4321-93eb-d278df849ccf/small/untitled-design-1-png.png https://www.guyanahealthreview.com/article/905898344-amarin-to-report-first-quarter-2026-financial-results-and-host-conference-call-on-april-29-2026 Guyana Health Review en PressRelease 2026-04-15T12:00:00+00:00 Amarin to Report First Quarter 2026 Financial Results and Host Conference Call on April 29, 2026 https://ml.globenewswire.com/media/00eeab93-e634-4279-86b3-7973c2a21623/small/amarin-logo-jpeg-jpg.jpg https://www.guyanahealthreview.com/article/905898944-sab-bio-to-present-additional-data-supporting-the-unique-profile-of-sab-142-at-the-2026-immunology-of-diabetes-society-congress Guyana Health Review en PressRelease 2026-04-15T12:00:00+00:00 SAB BIO to Present Additional Data Supporting the Unique Profile of SAB-142 at the 2026 Immunology of Diabetes Society Congress https://ml.globenewswire.com/media/6d99a771-f2c9-4d05-bf57-4f6c070df032/small/sabprimarylogocolorrgb900px72ppi-png.png https://www.guyanahealthreview.com/article/905899215-cue-biopharma-to-present-new-preclinical-data-on-lead-autoimmune-and-inflammatory-disease-candidate-cue-401-at-immunology2026 Guyana Health Review en PressRelease 2026-04-15T12:00:00+00:00 Cue Biopharma to Present New Preclinical Data on Lead Autoimmune and Inflammatory Disease Candidate CUE-401 at IMMUNOLOGY2026 https://ml.globenewswire.com/media/10541379-34cc-4869-a26f-fd99feead42a/small/cue-bio-brand-strategy-graphics-jpg.jpg https://www.guyanahealthreview.com/article/905900529-picard-medical-syncardia-highlights-total-artificial-heart-bridge-to-transplant-case-at-texas-children-s-hospital Guyana Health Review en PressRelease 2026-04-15T12:00:00+00:00 Picard Medical / SynCardia Highlights Total Artificial Heart Bridge to Transplant Case at Texas Children's Hospital https://ml.globenewswire.com/media/93c733bb-b54a-41af-856b-6d01c1f724a2/small/syncardia-x-picard-email-signature-2025-1-png.png https://www.guyanahealthreview.com/article/905901251-beyond-air-to-participate-in-the-d-boral-capital-global-conference-2026 Guyana Health Review en PressRelease 2026-04-15T12:00:00+00:00 Beyond Air to Participate in the D. Boral Capital Global Conference 2026 https://ml.globenewswire.com/media/c7ae3957-2763-4e5c-9594-57e1ba60ed59/small/beyond-air-the-magic-of-breathing-png.png https://www.guyanahealthreview.com/article/905901370-immutep-receives-fda-orphan-drug-designation-for-eftilagimod-alfa-in-soft-tissue-sarcoma Guyana Health Review en PressRelease 2026-04-15T12:00:00+00:00 Immutep Receives FDA Orphan Drug Designation for Eftilagimod Alfa in Soft Tissue Sarcoma https://ml.globenewswire.com/media/b2cd55d0-59ab-45ac-a1fe-5cf2adac7f24/small/immutep-new-logo-png.png https://www.guyanahealthreview.com/article/905901585-reviva-announces-letter-to-shareholders Guyana Health Review en PressRelease 2026-04-15T12:00:00+00:00 Reviva Announces Letter to Shareholders https://ml.globenewswire.com/media/1d8c6564-1da5-4561-b6ec-79de6d565869/small/reviva-logo-png.png https://www.guyanahealthreview.com/article/905901758-calidi-biotherapeutics-announces-participation-in-redchip-s-april-16-virtual-investor-conference-to-feature-companies-advancing-clinical-pipelines-and Guyana Health Review en PressRelease 2026-04-15T12:00:00+00:00 Calidi Biotherapeutics Announces Participation in RedChip’s April 16 Virtual Investor Conference to Feature Companies Advancing Clinical Pipelines and Scalable Healthcare Platforms https://ml.globenewswire.com/media/9e574b79-be62-4805-a4b4-cb0b7dcc5fbd/small/calidibiotherapeutics-logo-2x-jpg.jpg https://www.guyanahealthreview.com/article/905902114-filana-therapeutics-announces-publication-in-epilepsia-of-preclinical-simufilam-data Guyana Health Review en PressRelease 2026-04-15T12:00:00+00:00 Filana Therapeutics Announces Publication in Epilepsia of Preclinical Simufilam Data https://ml.globenewswire.com/media/877131cb-f6f1-4b81-99c9-d2ea829a9272/medium/epilepsia-paper-figure-3c.png https://www.guyanahealthreview.com/article/905902287-achieve-life-sciences-announces-operational-progress-including-completion-of-technology-transfer-to-adare-pharma-solutions Guyana Health Review en PressRelease 2026-04-15T12:00:00+00:00 Achieve Life Sciences Announces Operational Progress Including Completion of Technology Transfer to Adare Pharma Solutions https://ml.globenewswire.com/media/1026e030-275c-4391-8f9a-65c5c1ec7b88/small/achieve-logo-717x800px-2-1-jpg.jpg https://www.guyanahealthreview.com/article/905902588-callio-therapeutics-to-present-poster-on-clio-8221-a-novel-dual-payload-antibody-drug-conjugate-at-aacr-2026 Guyana Health Review en PressRelease 2026-04-15T12:00:00+00:00 Callio Therapeutics to Present Poster on CLIO-8221, a Novel Dual-Payload Antibody-Drug Conjugate, at AACR 2026 https://ml.globenewswire.com/media/3511fd62-eaba-4921-a3da-4e0b00d976e6/small/callio-logo-stacked-default-png.png https://www.guyanahealthreview.com/article/905902871-extendicare-announces-april-2026-dividend-of-c-0-0441-per-share Guyana Health Review en PressRelease 2026-04-15T12:00:00+00:00 Extendicare Announces April 2026 Dividend of C$0.0441 per Share https://ml.globenewswire.com/media/6d631964-eede-4e2c-912c-58ab7d1dc35f/small/extendicare-jpg.jpg https://www.guyanahealthreview.com/article/905902924-ai-enabled-fertility-care-and-longevity-provider-onto-health-closes-20-million-series-funded-by-artis-and-humania Guyana Health Review en PressRelease 2026-04-15T11:52:00+00:00 AI-Enabled Fertility Care and Longevity Provider ONTO Health Closes $20 Million Series funded by ARTIS and Humania https://ml.globenewswire.com/media/bfd2a283-62a3-4223-a85d-f2bbd3a71ec6/small/16017175-5a43-4a1c-bd49-824adef1a0fb-png.png https://www.guyanahealthreview.com/article/905880835-tilray-brands-accelerates-next-phase-of-global-growth-and-market-leadership Guyana Health Review en PressRelease 2026-04-15T11:40:44+00:00 Tilray Brands Accelerates Next Phase of Global Growth and Market Leadership https://ml.globenewswire.com/media/2dbf85bb-5e30-4623-8f9b-931442240c05/small/tilraybrands-logo-fullcolor-rbg-horiz-01-png.png https://www.guyanahealthreview.com/article/905879486-inside-the-science-new-white-paper-explores-the-injection-set-to-redefine-the-treatment-of-knee-osteoarthritis-unlock-access-to-non-surgical Guyana Health Review en PressRelease 2026-04-15T11:30:17+00:00 Inside the Science: New White Paper Explores the Injection Set to Redefine the Treatment of Knee Osteoarthritis & Unlock Access to Non-Surgical Options for Patients on the NHS https://ml-eu.globenewswire.com/media/OTcxNDdjMzktYjc5Yy00ODFkLWE3MGMtNDQyNDE5MGY5NjZiLTEzMjI2NDUtMjAyNi0wNC0xNS1lbg==/tiny/Contura-Orthopaedics-Ltd.png https://www.guyanahealthreview.com/article/905879341-medicus-pharma-to-present-new-teverelix-data-at-aace-2026-demonstrating-long-acting-hormone-suppression Guyana Health Review en PressRelease 2026-04-15T11:30:00+00:00 Medicus Pharma to Present New Teverelix Data at AACE 2026 Demonstrating Long-Acting Hormone Suppression https://ml.globenewswire.com/media/0f5af1d1-dfba-4810-baac-d1922c0558c1/small/medicus-logo-rgb-05-aspect-1500px-globe-newswire-2-jpg.jpg https://www.guyanahealthreview.com/article/905879590-brainsway-highlights-growing-u-s-payer-support-for-nurse-practitioner-administered-transcranial-magnetic-stimulation-tms-therapy Guyana Health Review en PressRelease 2026-04-15T11:30:00+00:00 BrainsWay Highlights Growing U.S. Payer Support for Nurse Practitioner-Administered Transcranial Magnetic Stimulation (TMS) Therapy https://ml.globenewswire.com/media/ea01c8f7-39be-46d2-a8e0-bc05994f170e/small/brainsway-2021-logo-jpg.jpg https://www.guyanahealthreview.com/article/905879729-arbutus-receives-u-s-fda-fast-track-designation-for-imdusiran-for-the-treatment-of-chronic-hepatitis-b Guyana Health Review en PressRelease 2026-04-15T11:30:00+00:00 Arbutus Receives U.S. FDA Fast Track Designation for Imdusiran for the Treatment of Chronic Hepatitis B https://ml.globenewswire.com/media/be474abd-3f6d-4270-a58e-1e6ee5c80bb2/small/arbutus-biopharma-logo.jpg https://www.guyanahealthreview.com/article/905879994-plus-therapeutics-appoints-randy-h-goodman-phd-mha-as-vice-president-of-value-strategy-heor-to-advance-market-access-and-commercial-execution Guyana Health Review en PressRelease 2026-04-15T11:30:00+00:00 Plus Therapeutics Appoints Randy H. Goodman, PhD, MHA, as Vice President of Value Strategy & HEOR to Advance Market Access and Commercial Execution https://ml.globenewswire.com/media/92d7aa70-e37d-4870-bccf-d83b68ba5612/small/plus-logo-png.png https://www.guyanahealthreview.com/article/905880421-prelude-therapeutics-announces-the-appointment-of-charles-morris-m-d-as-chief-medical-officer Guyana Health Review en PressRelease 2026-04-15T11:30:00+00:00 Prelude Therapeutics Announces the Appointment of Charles Morris, M.D. as Chief Medical Officer https://ml.globenewswire.com/media/cab62748-b61a-42cb-b552-b0c6c91c4e83/small/ptx-logo-png.png https://www.guyanahealthreview.com/article/905880501-tg-therapeutics-announces-completion-of-enrollment-for-the-phase-3-trial-evaluating-subcutaneous-briumvi Guyana Health Review en PressRelease 2026-04-15T11:30:00+00:00 TG Therapeutics Announces Completion of Enrollment for the Phase 3 Trial Evaluating Subcutaneous BRIUMVI https://ml.globenewswire.com/media/0e613f5f-8c22-4c63-a73b-c08cc0fbec64/small/tgtx-2021-logo.jpg https://www.guyanahealthreview.com/article/905880748-clearmind-medicine-announces-positive-data-safety-monitoring-board-recommendation-in-ongoing-cmnd-100-clinical-trial Guyana Health Review en PressRelease 2026-04-15T11:30:00+00:00 Clearmind Medicine Announces Positive Data Safety Monitoring Board Recommendation in ongoing CMND-100 clinical trial https://ml.globenewswire.com/media/bd17cbf4-8124-4f86-8a4c-1fafbb6785af/small/logo-jpg.jpg https://www.guyanahealthreview.com/article/905880639-alterity-therapeutics-to-host-virtual-kol-event-to-share-new-insights-on-ath434-for-the-treatment-of-multiple-system-atrophy Guyana Health Review en PressRelease 2026-04-15T11:25:00+00:00 Alterity Therapeutics to Host Virtual KOL Event to Share New Insights on ATH434 for the Treatment of Multiple System Atrophy https://ml.globenewswire.com/media/0771a9a2-2ac1-4a63-9767-a2b1df74af27/small/alterity-png.png https://www.guyanahealthreview.com/article/905879871-stereotaxis-announces-definitive-agreement-to-acquire-robocath Guyana Health Review en PressRelease 2026-04-15T11:00:00+00:00 Stereotaxis Announces Definitive Agreement to Acquire Robocath https://ml.globenewswire.com/media/95a5b8ca-b7c0-4c80-8ca7-063ef10706c3/small/stereotaxis-logo-new-tagline-black-text-png.png https://www.guyanahealthreview.com/article/905879928-biocryst-to-report-first-quarter-2026-financial-results-on-may-6 Guyana Health Review en PressRelease 2026-04-15T11:00:00+00:00 BioCryst to Report First Quarter 2026 Financial Results on May 6 https://ml.globenewswire.com/media/8b033909-1a3c-4811-b07b-fe03b12e00d2/small/biocryst-primarylogo-r-2c-rgb-jpg.jpg https://www.guyanahealthreview.com/article/905880212-orvida-pharma-formerly-kamari-pharma-announces-favorable-phase-1a-safety-data-for-km-023-a-potential-first-in-disease-oral-trpv3-inhibitor-and Guyana Health Review en PressRelease 2026-04-15T11:00:00+00:00 Orvida Pharma (formerly Kamari Pharma) Announces Favorable Phase 1a Safety Data for KM-023, a Potential First-in-Disease Oral TRPV3 Inhibitor, and Initiation of Phase 1b Study in Patients with Olmsted Syndrome https://ml.globenewswire.com/media/cd4d7fc1-6bca-4b1d-a6b3-2314ed21fb79/small/orvida-final-46-jpg.jpg https://www.guyanahealthreview.com/article/905880223-tonix-pharmaceuticals-announces-publication-of-steady-state-pharmacokinetics-of-tonmya-after-20-days-of-daily-dosing-in-the-peer-reviewed-journal Guyana Health Review en PressRelease 2026-04-15T11:00:00+00:00 Tonix Pharmaceuticals Announces Publication of Steady-State Pharmacokinetics of TONMYA® After 20 Days of Daily Dosing in the Peer-Reviewed Journal, Clinical Pharmacology in Drug Development https://ml.globenewswire.com/media/16aad249-3d33-4501-b3d9-118a703fa46e/small/tonix2-jpg.jpg https://www.guyanahealthreview.com/article/905880323-beeline-medicines-debuts-to-deliver-category-leading-precision-therapies-for-people-living-with-autoimmune-and-inflammatory-diseases Guyana Health Review en PressRelease 2026-04-15T11:00:00+00:00 Beeline Medicines Debuts to Deliver Category-Leading Precision Therapies for People Living with Autoimmune and Inflammatory Diseases https://ml.globenewswire.com/media/a870f826-b54c-4781-bf10-d8ce2db7245a/small/beelinemedicines-logo-fullcolor-png.png https://www.guyanahealthreview.com/article/905880568-nrx-pharmaceuticals-advances-robotic-enabled-transcranial-magnetic-stimulation-combined-with-neuroplastic-therapy-for-military-and-first-responder Guyana Health Review en PressRelease 2026-04-15T11:00:00+00:00 NRx Pharmaceuticals Advances Robotic-Enabled Transcranial Magnetic Stimulation Combined with Neuroplastic Therapy for Military and First Responder Applications https://ml.globenewswire.com/media/d879f1ff-d5d7-48d7-9731-c881b469d873/small/nrx-logo-300dpi-png.png https://www.guyanahealthreview.com/article/905880425-neffy-epinephrine-nasal-spray-approved-in-canada-as-the-first-and-only-needle-free-emergency-treatment-of-allergic-reactions-anaphylaxis Guyana Health Review en PressRelease 2026-04-15T10:05:00+00:00 neffy® (epinephrine nasal spray) Approved in Canada as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis) https://ml.globenewswire.com/media/8feeb9d1-ed0c-491a-988b-a2b54778e825/small/ars-logo-png.png https://www.guyanahealthreview.com/article/905862956-alivecor-bringt-das-ki-gest-tzte-kardia-12l-in-europa-auf-den-markt-das-weltweit-erste-tragbare-12-kanal-ekg-mit-einzigartigem-ein-kabel-design Guyana Health Review en PressRelease 2026-04-15T08:01:00+00:00 AliveCor bringt das KI-gestützte Kardia 12L in Europa auf den Markt: Das weltweit erste tragbare 12-Kanal-EKG mit einzigartigem Ein-Kabel-Design https://ml.globenewswire.com/media/ca97a5ad-9227-4559-a41a-59468d5bc246/small/alivecor-rgb-horizontal-blue-2-png.png https://www.guyanahealthreview.com/article/905863061-alivecor-lanza-en-europa-el-kardia-12l-un-dispositivo-con-ia-el-primer-ecg-port-til-de-12-derivaciones-del-mundo-con-un-dise-o-nico-de-un-solo Guyana Health Review en PressRelease 2026-04-15T08:01:00+00:00 AliveCor lanza en Europa el Kardia 12L, un dispositivo con IA: el primer ECG portátil de 12 derivaciones del mundo con un diseño único de un solo cable https://ml.globenewswire.com/media/ca97a5ad-9227-4559-a41a-59468d5bc246/small/alivecor-rgb-horizontal-blue-2-png.png https://www.guyanahealthreview.com/article/905863140-lancement-par-alivecor-du-kardia-12l-aliment-par-l-ia-en-europe-le-premier-ecg-portable-12-d-rivations-au-monde-dot-d-une-conception-in-dite Guyana Health Review en PressRelease 2026-04-15T08:01:00+00:00 Lancement par AliveCor du Kardia 12L alimenté par l’IA en Europe : le premier ECG portable à 12 dérivations au monde, doté d’une conception inédite à câble unique https://ml.globenewswire.com/media/ca97a5ad-9227-4559-a41a-59468d5bc246/small/alivecor-rgb-horizontal-blue-2-png.png https://www.guyanahealthreview.com/article/905863200-alivecor-lancia-in-europa-kardia-12l-basato-su-intelligenza-artificiale-il-primo-ecg-portatile-a-12-derivazioni-al-mondo-con-un-esclusivo-design-a Guyana Health Review en PressRelease 2026-04-15T08:01:00+00:00 AliveCor lancia in Europa Kardia 12L basato su intelligenza artificiale: il primo ECG portatile a 12 derivazioni al mondo con un esclusivo design a cavo singolo https://ml.globenewswire.com/media/ca97a5ad-9227-4559-a41a-59468d5bc246/small/alivecor-rgb-horizontal-blue-2-png.png https://www.guyanahealthreview.com/article/905863241-alivecor-lanceert-de-ai-gestuurde-kardia-12l-in-europa-s-werelds-eerste-draagbare-12-afleidingen-ecg-met-een-uniek-ontwerp-met-n-kabel Guyana Health Review en PressRelease 2026-04-15T08:01:00+00:00 AliveCor lanceert de AI-gestuurde Kardia 12L in Europa: 's werelds eerste draagbare 12-afleidingen-ECG met een uniek ontwerp met één kabel https://ml.globenewswire.com/media/ca97a5ad-9227-4559-a41a-59468d5bc246/small/alivecor-rgb-horizontal-blue-2-png.png https://www.guyanahealthreview.com/article/905863456-alivecor-launches-ai-powered-kardia-12l-in-europe-the-world-s-first-handheld-12-lead-ecg-with-a-unique-single-cable-design Guyana Health Review en PressRelease 2026-04-15T08:01:00+00:00 AliveCor Launches AI-Powered Kardia 12L in Europe: The World’s First Handheld 12-Lead ECG with a Unique Single-Cable Design https://ml.globenewswire.com/media/d510c9dc-7eb1-45bd-ba22-aa01f14d3e40/medium/alivecor-s-kardia-12l-launches-in-europe.png https://www.guyanahealthreview.com/article/905862487-c-mo-medical-solutions-receives-ce-mark-for-its-novel-ai-powered-cough-monitoring-solution Guyana Health Review en PressRelease 2026-04-15T08:00:00+00:00 C-mo Medical Solutions Receives CE Mark for Its Novel AI-Powered Cough Monitoring Solution https://ml-eu.globenewswire.com/media/MjJkZjIyNmItZDRjYi00MjIyLWI0ZTgtNGU4MzI0MjEyN2FiLTEwMzc0NTQtMjAyNi0wNC0xNS1lbg==/tiny/AKAMPION.png https://www.guyanahealthreview.com/article/905843465-minervax-strengthens-executive-leadership-team-with-two-strategic-appointments-as-it-advances-its-maternal-gbs-vaccine-towards-pivotal-trial Guyana Health Review en PressRelease 2026-04-15T07:30:00+00:00 MinervaX Strengthens Executive Leadership Team with Two Strategic Appointments as it Advances its Maternal GBS Vaccine Towards Pivotal Trial Initiation https://ml-eu.globenewswire.com/media/e8d7e6c7-c95d-4c2e-85d8-7c656c5ee8f5/small/minervax-logo-png.png https://www.guyanahealthreview.com/article/905844405-notice-of-issuance-of-new-shares-in-connection-with-the-introduction-of-the-employee-stock-ownership-plan-matters-relating-to-stock-units-and Guyana Health Review en PressRelease 2026-04-15T06:34:41+00:00 Notice of Issuance of New Shares in Connection with the Introduction of the Employee Stock Ownership Plan, Matters Relating to Stock Units and Determination of Payment Amount and Other Matters of Issuance of New Shares Under Prior RSU Award https://ml-eu.globenewswire.com/media/5cc74d52-c86f-4e21-8684-3496281fee15/small/nxera-master-logo-rgb-black-1-png.png https://www.guyanahealthreview.com/article/905844939-clinuvel-advancing-peptides-for-photomedicine-and-vitiligo-care-at-aad-2026 Guyana Health Review en PressRelease 2026-04-15T06:18:07+00:00 CLINUVEL: advancing peptides for photomedicine and vitiligo care at AAD 2026 https://ml.globenewswire.com/media/a63efa41-50f1-45f2-8ee5-0d54842edcaa/medium/clinuvels-pavilion-of-photomedicine-at-aad-2026.jpg https://www.guyanahealthreview.com/article/905843826-aerska-strengthens-leadership-and-board-with-key-appointments-to-advance-systemically-delivered-rna-medicines-for-the-brain Guyana Health Review en PressRelease 2026-04-15T06:00:00+00:00 Aerska Strengthens Leadership and Board with Key Appointments to Advance Systemically Delivered RNA Medicines for the Brain https://ml-eu.globenewswire.com/media/a4eb676a-dff5-4c91-a519-c5b46087f6f1/small/aerska-logo-1-png.png https://www.guyanahealthreview.com/article/905843928-citryll-strengthens-intellectual-property-portfolio-with-grant-of-european-composition-of-matter-patent-for-cit-013 Guyana Health Review en PressRelease 2026-04-15T06:00:00+00:00 Citryll Strengthens Intellectual Property Portfolio With Grant of European Composition of Matter Patent for CIT-013 https://ml-eu.globenewswire.com/media/34e26d4c-9c72-4edc-a853-633cca05b108/small/1-citryll-logo-rgb-002-png.png https://www.guyanahealthreview.com/article/905824743-ose-immunotherapeutics-to-present-a-novel-first-in-class-fpr2-agonist-monoclonal-antibody-in-the-resolution-of-chronic-inflammation-at-the-aai-2026 Guyana Health Review en PressRelease 2026-04-15T05:30:00+00:00 OSE Immunotherapeutics to Present a Novel, First-in-Class, FPR2 Agonist Monoclonal Antibody in the Resolution of Chronic Inflammation at the AAI 2026 Meeting https://ml-eu.globenewswire.com/media/e79ae2c6-fc13-4a02-9759-4ecc9c4fdb22/small/ose-logo-horizontal-rvb-png.png https://www.guyanahealthreview.com/article/905824755-ose-immunotherapeutics-pr-sentera-un-nouvel-anticorps-monoclonal-first-in-class-agoniste-de-fpr2-dans-la-r-solution-de-l-inflammation-chronique-au Guyana Health Review en PressRelease 2026-04-15T05:30:00+00:00 OSE Immunotherapeutics présentera un nouvel anticorps monoclonal, first-in-class, agoniste de FPR2 dans la résolution de l’inflammation chronique au Congrès 2026 de l’AAI https://ml-eu.globenewswire.com/media/e79ae2c6-fc13-4a02-9759-4ecc9c4fdb22/small/ https://www.guyanahealthreview.com/article/905824846-bioversys-to-present-data-on-clinical-and-preclinical-pipeline-programs-at-escmid-global-2026 Guyana Health Review en PressRelease 2026-04-15T05:00:00+00:00 BioVersys to Present Data on Clinical and Preclinical Pipeline Programs at ESCMID Global 2026 https://ml.globenewswire.com/media/37dee549-5eb0-418f-a16c-11d8422babfb/small/logo-bioversys-color-rgb-neu-for-prs-jpg.jpg https://www.guyanahealthreview.com/article/905824961-revolution-medicines-inc-prices-2-0-billion-in-concurrent-upsized-offerings-of-common-stock-and-convertible-senior-notes Guyana Health Review en PressRelease 2026-04-15T04:41:13+00:00 Revolution Medicines, Inc. Prices $2.0 Billion in Concurrent Upsized Offerings of Common Stock and Convertible Senior Notes https://ml.globenewswire.com/media/771b34d9-586d-435a-a976-ab0ab847571b/small/balanced-green-primary-logo-medium-1000px-png.png https://www.guyanahealthreview.com/article/905808332-spyre-therapeutics-announces-pricing-of-upsized-403-0-million-public-offering-of-common-stock Guyana Health Review en PressRelease 2026-04-15T02:38:25+00:00 Spyre Therapeutics Announces Pricing of Upsized $403.0 Million Public Offering of Common Stock https://ml.globenewswire.com/media/bc26a912-b583-43c6-8423-55a4ba2bf4bd/small/spyre-logo-horizontal-full-color-rgb-583px-300ppi-jpg.jpg https://www.guyanahealthreview.com/article/905808311-lecom-makes-pharmacy-education-more-accessible-with-three-fully-accredited-doctor-of-pharmacy-pathways Guyana Health Review en PressRelease 2026-04-15T02:31:27+00:00 LECOM Makes Pharmacy Education More Accessible with Three Fully Accredited Doctor of Pharmacy Pathways https://ml.globenewswire.com/Resource/Download/53969c12-c282-4b1a-a914-4ac7480a61e3/image1.jpeg https://www.guyanahealthreview.com/article/905790975-allogene-therapeutics-announces-pricing-of-public-offering-of-common-stock Guyana Health Review en PressRelease 2026-04-15T01:50:00+00:00 Allogene Therapeutics Announces Pricing of Public Offering of Common Stock https://ml.globenewswire.com/media/87e8712c-0741-409f-9942-c91b31e7c5e1/small/allogene-png.png https://www.guyanahealthreview.com/article/905790950-american-addiction-centers-and-filmmaker-jeffrey-shulman-team-up-to-promote-powerful-new-film-on-addiction-and-recovery-with-national-theatrical-tour Guyana Health Review en PressRelease 2026-04-15T01:17:26+00:00 American Addiction Centers and Filmmaker Jeffrey Shulman Team Up to Promote Powerful New Film on Addiction and Recovery with National Theatrical Tour https://ml.globenewswire.com/media/1cd36806-58ee-4d6f-935f-bd2088746d5d/medium/what-it-takes-official-film-poster.JPG https://www.guyanahealthreview.com/article/905790908-arc-trt-launches-new-website-to-help-uk-men-access-personalised-testosterone-replacement-therapy Guyana Health Review en PressRelease 2026-04-15T01:03:33+00:00 Arc TRT Launches New Website to Help UK Men Access Personalised Testosterone Replacement Therapy https://ml.globenewswire.com/media/adfa345c-868c-4bca-bdda-15d2ab4d6315/small/arc-trt-png.png https://www.guyanahealthreview.com/article/905791055-epimab-biotherapeutics-to-present-a-novel-prodrug-t-cell-engager-protce-platform-at-the-2026-american-association-for-cancer-research-annual-meeting Guyana Health Review en PressRelease 2026-04-15T01:00:00+00:00 EpimAb Biotherapeutics to Present a Novel Prodrug T-Cell Engager (ProTCE) Platform at the 2026 American Association for Cancer Research Annual Meeting https://ml.globenewswire.com/media/fa1bd13e-e49a-4b2c-a742-85957a03ad87/small/epimab-logo-for-notified-png.png https://www.guyanahealthreview.com/article/905776369-mesoblast-acquires-chimeric-antigen-receptor-car-platform-technology-for-precision-enhanced-cell-products Guyana Health Review en PressRelease 2026-04-15T00:10:56+00:00 Mesoblast Acquires Chimeric Antigen Receptor (CAR) Platform Technology for Precision-Enhanced Cell Products https://ml.globenewswire.com/media/a9938a8a-a0ba-4708-abd5-2219515343fc/small/mesologo-png.png https://www.guyanahealthreview.com/article/905776367-telix-doses-first-patient-in-phase-3-ipax-bright-trial-of-tlx101-tx-for-recurrent-glioblastoma Guyana Health Review en PressRelease 2026-04-14T23:04:43+00:00 Telix Doses First Patient in Phase 3 IPAX-BrIGHT Trial of TLX101-Tx for Recurrent Glioblastoma https://ml.globenewswire.com/media/77ceffdf-31cc-415f-9747-efee950af329/small/telix-main-logo-3-png.png https://www.guyanahealthreview.com/article/905763136-bruno-mars-presents-1-million-gift-to-intermountain-health-for-the-future-nevada-children-s-hospital Guyana Health Review en PressRelease 2026-04-14T21:40:23+00:00 Bruno Mars Presents $1 Million Gift to Intermountain Health for the Future Nevada Children’s Hospital https://ml.globenewswire.com/media/OGZmZTRlNzItNGMwOS00NDY4LWJlNzgtZGRiNjk5Mjc4ODU1LTEyNjkxMjYtMjAyNi0wNC0xNC1lbg==/tiny/Intermountain-Health.png https://www.guyanahealthreview.com/article/905763051-lymph-tonic-claims-evaluated-the-forbidden-enzyme-protocol-for-safe-weight-loss-support-by-lymphtonic Guyana Health Review en PressRelease 2026-04-14T21:37:48+00:00 Lymph Tonic Claims Evaluated: The Forbidden Enzyme Protocol for Safe Weight Loss Support by LymphTonic https://zingfast.com/wp-content/uploads/2026/04/Lymph-Tonic.jpg https://www.guyanahealthreview.com/article/905762991-enlitic-announces-ensight-2-2-a-breakthrough-in-imaging-data-standardization Guyana Health Review en PressRelease 2026-04-14T21:29:27+00:00 Enlitic Announces Ensight 2.2, a Breakthrough in Imaging Data Standardization https://ml.globenewswire.com/media/372da620-5254-4763-8d1e-53195694c648/medium/enlitic-announces-ensight-2-2-a-breakthrough-in-imaging-data.jpg https://www.guyanahealthreview.com/article/905750683-lemaitre-will-announce-first-quarter-2026-earnings-results-on-may-5-2026 Guyana Health Review en PressRelease 2026-04-14T20:54:05+00:00 LeMaitre Will Announce First Quarter 2026 Earnings Results on May 5, 2026 https://ml.globenewswire.com/media/8b8755b7-6f04-4650-9c94-0a2d0654fd49/small/lemaitre-2color-rgb-jpg.jpg https://www.guyanahealthreview.com/article/905749724-ankalax-claims-evaluated-effective-ankle-massager-brace-with-heat-therapy-vibration-compression-for-recovery Guyana Health Review en PressRelease 2026-04-14T20:28:01+00:00 Ankalax Claims Evaluated: Effective Ankle Massager Brace with Heat Therapy + Vibration Compression for Recovery https://zingfast.com/wp-content/uploads/2026/04/Ankalax-Ankle-Massage-Brace.jpg https://www.guyanahealthreview.com/article/905749617-update-r1-announces-phare-os-expansion-to-help-providers-navigate-growing-complexity-and-margin-pressure Guyana Health Review en PressRelease 2026-04-14T20:25:34+00:00 UPDATE - R1 Announces Phare OS Expansion to Help Providers Navigate Growing Complexity and Margin Pressure https://ml.globenewswire.com/media/728189a4-e254-443f-8452-315403fd70f4/small/r1-logo-black-25-947x676-jpg.jpg https://www.guyanahealthreview.com/article/905748202-heartsciences-reminds-its-shareholders-to-submit-their-vote-at-the-upcoming-april-30-2026-annual-shareholders-meeting Guyana Health Review en PressRelease 2026-04-14T20:15:00+00:00 HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting https://ml.globenewswire.com/media/800a6aae-74f3-42bb-9199-5e169ed9b881/small/heartsciences-png.png https://www.guyanahealthreview.com/article/905748222-aligos-therapeutics-announces-first-interim-analysis-results-from-the-phase-2-b-supreme-study-of-pevifoscorvir-sodium-in-participants-with-chronic Guyana Health Review en PressRelease 2026-04-14T20:05:00+00:00 Aligos Therapeutics Announces First Interim Analysis Results from the Phase 2 B-SUPREME Study of Pevifoscorvir Sodium in Participants with Chronic Hepatitis B Virus Infection and Grant of FDA Fast Track Designation https://ml.globenewswire.com/media/03ffbe89-c47f-4f83-b51f-f13a572e2cd1/small/aligos-png.png https://www.guyanahealthreview.com/article/905748406-structure-therapeutics-appoints-matthew-lang-j-d-as-chief-operating-officer-and-general-counsel Guyana Health Review en PressRelease 2026-04-14T20:05:00+00:00 Structure Therapeutics Appoints Matthew Lang, J.D. as Chief Operating Officer and General Counsel https://ml.globenewswire.com/media/154be1d7-62d7-4688-be20-3b2a10a2628e/small/structure-therapeutics-png.png https://www.guyanahealthreview.com/article/905748488-geron-corporation-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4 Guyana Health Review en PressRelease 2026-04-14T20:05:00+00:00 Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/e184bb51-5636-436e-8964-15613f24ca1f/small/geron-logo-jpg.jpg https://www.guyanahealthreview.com/article/905748979-canadian-animal-health-institute-unleashes-cutest-pets-on-parliament-hill Guyana Health Review en PressRelease 2026-04-14T20:00:00+00:00 Canadian Animal Health Institute Unleashes Cutest Pets on Parliament Hill  https://ml.globenewswire.com/media/197c2953-84e0-435d-8524-c68da19d27e9/small/cahi-logo-jpg.JPG https://www.guyanahealthreview.com/article/905748980-l-institut-canadien-de-la-sant-animale-lib-re-les-animaux-de-compagnie-les-plus-mignons-sur-la-colline-du-parlement Guyana Health Review en PressRelease 2026-04-14T20:00:00+00:00 L’Institut canadien de la santé animale libère les animaux de compagnie les plus mignons sur la Colline du Parlement  https://ml.globenewswire.com/media/197c2953-84e0-435d-8524-c68da19d27e9/small/cahi-logo-jpg.JPG https://www.guyanahealthreview.com/article/905736235-national-roundtable-advances-women-s-health-and-chronic-pain-research-in-canada Guyana Health Review en PressRelease 2026-04-14T19:17:30+00:00 National Roundtable Advances Women’s Health and Chronic Pain Research in Canada https://ml.globenewswire.com/media/32c18902-bbfd-4447-afb8-37712906af67/small/centre-of-excellence-logo-png.png https://www.guyanahealthreview.com/article/905736758-la-table-ronde-nationale-fait-progresser-les-recherches-sur-la-sant-et-la-douleur-chronique-au-canada Guyana Health Review en PressRelease 2026-04-14T19:17:30+00:00 La table ronde nationale fait progresser les recherches sur la santé et la douleur chronique au Canada https://ml.globenewswire.com/media/32c18902-bbfd-4447-afb8-37712906af67/small/centre-of-excellence-logo-png.png https://www.guyanahealthreview.com/article/905736407-dr-eric-haeger-establishes-new-scholarship-program-to-support-future-medical-professionals-and-healthcare-innovation Guyana Health Review en PressRelease 2026-04-14T19:07:19+00:00 Dr. Eric Haeger Establishes New Scholarship Program to Support Future Medical Professionals and Healthcare Innovation https://ml.globenewswire.com/media/46ed0337-1c54-4d9f-b03a-6578ae568fc8/medium/dr-eric-haeger-scholarship.png https://www.guyanahealthreview.com/article/905735070-adcare-hospital-hosts-eagle-scout-led-initiative-to-support-patients-in-recovery Guyana Health Review en PressRelease 2026-04-14T18:45:00+00:00 AdCare Hospital Hosts Eagle Scout-Led Initiative to Support Patients in Recovery https://ml.globenewswire.com/media/d233fb10-552e-4814-b746-a0797cce4b93/small/logo-adcare-png.png https://www.guyanahealthreview.com/article/905735131-exit-156-capital-and-nightware-announce-strategic-investment-partnership Guyana Health Review en PressRelease 2026-04-14T18:33:00+00:00 EXIT 156 CAPITAL AND NIGHTWARE ANNOUNCE STRATEGIC INVESTMENT PARTNERSHIP https://ml.globenewswire.com/media/a6f5b4f9-8819-48df-bbb5-58f7d222ab16/small/nightware-inc-logo.png https://www.guyanahealthreview.com/article/905734763-microbot-medical-to-highlight-commercial-achievements-leading-to-the-full-market-release-fmr-of-the-liberty-endovascular-robotic-system-at-the Guyana Health Review en PressRelease 2026-04-14T18:30:00+00:00 Microbot Medical® to Highlight Commercial Achievements Leading to the Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System at the 25th Annual Needham Virtual Healthcare Conference https://ml.globenewswire.com/media/346df7fb-c134-40c2-970a-39bcbaf974cd/small/mbot-logo-rgb-jpg.jpg https://www.guyanahealthreview.com/article/905735393-supporting-women-s-health-can-unlock-workforce-potential-here-s-what-employers-and-allies-can-do Guyana Health Review en PressRelease 2026-04-14T18:24:12+00:00 Supporting Women’s Health Can Unlock Workforce Potential. Here’s What Employers and Allies Can Do https://ml.globenewswire.com/media/669af2b2-a5eb-433a-b6da-54ef95a7977b/small/whcc-logo-jpg.jpg https://www.guyanahealthreview.com/article/905735430-le-soutien-la-sant-des-femmes-maximise-le-potentiel-de-la-main-d-uvre-voici-comment-les-employeurs-et-les-alli-s-peuvent-aider Guyana Health Review en PressRelease 2026-04-14T18:24:12+00:00 Le soutien à la santé des femmes maximise le potentiel de la main-d’œuvre. Voici comment les employeurs et les alliés peuvent aider https://ml.globenewswire.com/media/669af2b2-a5eb-433a-b6da-54ef95a7977b/small/whcc-logo-jpg.jpg https://www.guyanahealthreview.com/article/905735110-scripps-encinitas-named-among-top-100-hospitals-in-the-u-s Guyana Health Review en PressRelease 2026-04-14T18:17:15+00:00 Scripps Encinitas Named Among Top 100 Hospitals in the U.S. https://ml.globenewswire.com/media/Y2Q0NWE4NGUtZjcyNi00NDM4LWJjMDQtNGRiYWE5MGJkODI4LTExMDA0OTEtMjAyNi0wNC0xNC1lbg==/tiny/Scripps-Health.png https://www.guyanahealthreview.com/article/905735261-galera-therapeutics-and-obsidian-therapeutics-announce-merger-agreement-and-350-million-concurrent-private-placement Guyana Health Review en PressRelease 2026-04-14T18:08:10+00:00 Galera Therapeutics and Obsidian Therapeutics Announce Merger Agreement and $350 Million Concurrent Private Placement https://ml.globenewswire.com/media/d4232a7c-0097-427f-af68-18288ab26fa6/small/galera-logo-jpg.jpg https://www.guyanahealthreview.com/article/905721688-excellent-brain-ltd-launches-new-android-version-for-neurofeedback-for-adhd-platform Guyana Health Review en PressRelease 2026-04-14T17:29:00+00:00 Excellent Brain Ltd. Launches New Android Version for Neurofeedback for ADHD Platform https://pressranger.s3.us-west-1.amazonaws.com/3230185/WhatsApp-Image-2026-04-05-at-12.59.39.jpeg https://www.guyanahealthreview.com/article/905721597-van-nuys-premier-rehabilitation-center-injury-docs-celebrates-10-000th-patient Guyana Health Review en PressRelease 2026-04-14T16:37:00+00:00 Van Nuys' Premier Rehabilitation Center, Injury Docs, Celebrates 10,000th Patient https://pressranger.s3.us-west-1.amazonaws.com/3228271/SCR-20260410-mizp.png https://www.guyanahealthreview.com/article/905707675-ose-immunotherapeutics-evolves-its-leadership-team Guyana Health Review en PressRelease 2026-04-14T16:00:00+00:00 OSE Immunotherapeutics Evolves its Leadership Team https://ml-eu.globenewswire.com/media/e79ae2c6-fc13-4a02-9759-4ecc9c4fdb22/small/ose-logo-horizontal-rvb-png.png https://www.guyanahealthreview.com/article/905707763-ose-immunotherapeutics-fait-voluer-son-quipe-de-direction Guyana Health Review en PressRelease 2026-04-14T16:00:00+00:00 OSE Immunotherapeutics fait évoluer son équipe de direction https://ml-eu.globenewswire.com/media/e79ae2c6-fc13-4a02-9759-4ecc9c4fdb22/small/ https://www.guyanahealthreview.com/article/905708063-comprehensive-healthcare-launches-just-in-time-prescriber-scheduling-to-improve-access-to-behavioral-health-medication-services Guyana Health Review en PressRelease 2026-04-14T16:00:00+00:00 Comprehensive Healthcare Launches “Just In Time” Prescriber Scheduling to Improve Access to Behavioral Health Medication Services https://ml.globenewswire.com/media/87b3c91d-8292-48c4-aaff-e3ee4e518ee3/small/ch-logo-jpg.jpg https://www.guyanahealthreview.com/article/905708364-providence-saint-john-s-health-center-announces-largest-philanthropic-gift-in-its-history-through-transformative-stan-lucas-legacy Guyana Health Review en PressRelease 2026-04-14T16:00:00+00:00 Providence Saint John’s Health Center Announces Largest Philanthropic Gift in Its History Through Transformative Stan Lucas Legacy https://ml.globenewswire.com/media/5cec38c7-016b-458b-b0cf-462a36e4f605/small/saintjohnshealthcenter-2l-clr-4cp-lowerres-jpg.jpg https://www.guyanahealthreview.com/article/905708957-ascellahealth-inaugurates-strategic-advisory-council-with-founding-members-advances-pharmacy-benefits-ecosystem-through-technology-deployment-and Guyana Health Review en PressRelease 2026-04-14T15:30:00+00:00 AscellaHealth Inaugurates Strategic Advisory Council, With Founding Members, Advances Pharmacy Benefits Ecosystem Through Technology Deployment and Specialty Expertise https://ml.globenewswire.com/media/5278c55f-330c-41a1-8446-d8b1a07bbc55/small/ah-logo-colornotag-4x-png.png https://www.guyanahealthreview.com/article/905699380-vietnam-shocks-the-world-with-animal-to-human-organ-transplantation-technology Guyana Health Review en PressRelease 2026-04-14T14:56:25+00:00 Vietnam Shocks the World With Animal-To-Human Organ Transplantation Technology https://ml.globenewswire.com/media/8986a8b7-9a74-40ca-bd2f-eef76084e773/medium/vgct-s-source.jpg https://www.guyanahealthreview.com/article/905695842-major-shareholder-announcement Guyana Health Review en PressRelease 2026-04-14T14:44:22+00:00 Major Shareholder Announcement https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg https://www.guyanahealthreview.com/article/905697702-advanced-radiation-centers-of-new-york-launches-softray-therapy-offering-new-non-surgical-relief-of-inflammatory-tendon-and-arthritis-pain Guyana Health Review en PressRelease 2026-04-14T14:04:00+00:00 Advanced Radiation Centers of New York Launches SoftRay™ Therapy, Offering New Non-Surgical Relief of Inflammatory, Tendon and Arthritis Pain https://ml.globenewswire.com/media/de310bc0-7bc1-48f5-b455-ca8f8ffd0472/medium/softray-therapy-logo.png https://www.guyanahealthreview.com/article/905695461-zealand-pharma-appoints-eric-rojas-as-vice-president-and-head-of-investor-relations Guyana Health Review en PressRelease 2026-04-14T14:00:00+00:00 Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations https://ml-eu.globenewswire.com/media/b505bacc-6953-4eb4-ab25-e03008f97b92/medium/eric-rojas.jpg https://www.guyanahealthreview.com/article/905696037-award-winning-medical-alert-system-bay-alarm-medical-launches-caregiver-sos-youtube-series-to-support-family-caregivers Guyana Health Review en PressRelease 2026-04-14T14:00:00+00:00 Award-winning Medical Alert System Bay Alarm Medical Launches 'Caregiver SOS' YouTube Series to Support Family Caregivers https://pressranger.s3.us-west-1.amazonaws.com/3140430/Screenshot-2026-03-06-at-12.32.15%E2%80%AFPM.png https://www.guyanahealthreview.com/article/905696490-neion-bio-strengthens-genome-engineering-leadership-with-appointment-of-colossal-biosciences-veteran-james-kehler Guyana Health Review en PressRelease 2026-04-14T14:00:00+00:00 Neion Bio Strengthens Genome Engineering Leadership with Appointment of Colossal Biosciences Veteran James Kehler https://ml.globenewswire.com/media/e37518bc-d9ef-45ce-99a7-35e82f143444/medium/dr-james-kehler.jpg https://www.guyanahealthreview.com/article/905696688-reducing-administrative-burden-raises-medicaid-provider-satisfaction-by-50-new-study-finds Guyana Health Review en PressRelease 2026-04-14T14:00:00+00:00 Reducing Administrative Burden Raises Medicaid Provider Satisfaction by 50%, New Study Finds https://ml.globenewswire.com/media/24cdff2f-7c95-4f21-aebb-25c4628d94e7/small/gainwell-logo-suite-061720-logosuite-png-gainwell-logo-150-r.png https://www.guyanahealthreview.com/article/905697695-hibercell-to-present-preclinical-data-demonstrating-the-enhanced-antitumor-activity-of-hc-7366-in-combination-with-vegfr-tkis-in-clear-cell-renal-cell Guyana Health Review en PressRelease 2026-04-14T14:00:00+00:00 HiberCell to Present Preclinical Data Demonstrating the Enhanced Antitumor Activity of HC-7366 in Combination with VEGFR-TKIs in Clear Cell Renal Cell Carcinoma (ccRCC) https://ml.globenewswire.com/media/d168805a-8691-40f2-abcf-fb63a607f112/small/hybercell-jpg.jpg https://www.guyanahealthreview.com/article/905697837-grand-river-aseptic-manufacturing-announces-100-million-investment-in-sterile-manufacturing-capabilities Guyana Health Review en PressRelease 2026-04-14T13:55:44+00:00 Grand River Aseptic Manufacturing Announces $100 Million Investment in Sterile Manufacturing Capabilities https://ml.globenewswire.com/media/OTBkMmRlZDktNGMxYi00Mjk1LWE0YWMtZTBhYjhlOTMyMTFhLTUwMDE1MTE4Ny0yMDI2LTA0LTE0LWVu/tiny/Grand-River-Aseptic-Manufactur.png https://www.guyanahealthreview.com/article/905697955-penn-highlands-healthcare-addresses-community-needs Guyana Health Review en PressRelease 2026-04-14T13:44:34+00:00 Penn Highlands Healthcare Addresses Community Needs https://ml.globenewswire.com/media/ZGEyZjE1ZWMtZDA4MC00MmM1LWI0ZmQtNmVlMTM5ODUxMDgzLTEyNTYxMzgtMjAyNi0wNC0xNC1lbg==/tiny/Penn-Highlands-Healthcare.png https://www.guyanahealthreview.com/article/905686836-culture-biosciences-announces-strategic-addition-to-its-board-of-directors-to-accelerate-hardware-commercialization-and-saas-growth Guyana Health Review en PressRelease 2026-04-14T13:30:00+00:00 Culture Biosciences Announces Strategic Addition to Its Board of Directors to Accelerate Hardware Commercialization and SaaS Growth https://ml.globenewswire.com/media/ce8c1148-eecd-40b0-b1b7-f858ab8c3c4f/small/culture-logo-one-color-rgb-1500px-300ppi-1-1-png.png https://www.guyanahealthreview.com/article/905685691-virtuix-delivers-omni-one-to-florida-gulf-coast-university-for-use-in-physical-therapy-and-clinical-simulation Guyana Health Review en PressRelease 2026-04-14T13:15:00+00:00 Virtuix Delivers Omni One to Florida Gulf Coast University for Use in Physical Therapy and Clinical Simulation https://ml.globenewswire.com/media/2ba7d28b-48bc-45db-b49e-929295456dc1/medium/omni-one-at-fgu-s-marieb-college-of-health-and-human-service.jpeg https://www.guyanahealthreview.com/article/905685932-myriad-genetics-expands-access-for-mychoice-test-to-prostate-cancer-patients-in-japan Guyana Health Review en PressRelease 2026-04-14T13:15:00+00:00 Myriad Genetics Expands Access for MyChoice Test to Prostate Cancer Patients in Japan https://ml.globenewswire.com/media/5cb679cf-5a10-4b95-8cf7-fd1d0b56721a/small/myriad-s-stacked-png.png https://www.guyanahealthreview.com/article/905685481-nextech-reduces-healthcare-s-payment-reconciliation-burden-with-reimagined-embedded-payment-processing-platform Guyana Health Review en PressRelease 2026-04-14T13:00:00+00:00 Nextech Reduces Healthcare’s Payment Reconciliation Burden with Reimagined Embedded Payment Processing Platform https://ml.globenewswire.com/media/2b32c79b-9e9d-48d1-ae49-77d47537ae62/small/nextech-logo-jpg-jpg.jpg https://www.guyanahealthreview.com/article/905685781-alliance-direct-benefits-launches-alliance-complete-as-demand-grows-for-simplified-bundled-support-offerings Guyana Health Review en PressRelease 2026-04-14T13:00:00+00:00 Alliance Direct Benefits Launches Alliance Complete as Demand Grows for Simplified, Bundled Support Offerings https://ml.globenewswire.com/media/ZGM1MDA4YTEtODYzZi00YzgzLThkODAtMjEwNWJhZjU2NjQ2LTUwMDE2MDEwNC0yMDI2LTA0LTE0LWVu/tiny/Alliance-Direct-Benefits.png https://www.guyanahealthreview.com/article/905686904-healthedge-partners-with-ellipsis-health-to-scale-care-management-through-ai-powered-virtual-nursing Guyana Health Review en PressRelease 2026-04-14T13:00:00+00:00 HealthEdge® Partners with Ellipsis Health to Scale Care Management Through AI-Powered Virtual Nursing https://ml.globenewswire.com/media/18d2dfaf-8f95-4f15-99e6-ae8282b42123/small/healthedge-logo-jpg.jpg https://www.guyanahealthreview.com/article/905686993-neomorph-to-highlight-progress-in-targeted-protein-degradation-science-at-the-american-association-for-cancer-research-annual-meeting Guyana Health Review en PressRelease 2026-04-14T13:00:00+00:00 Neomorph to Highlight Progress in Targeted Protein Degradation Science at the American Association for Cancer Research Annual Meeting https://ml.globenewswire.com/media/d00180c1-5def-41b6-95c7-018ca5e07565/small/neomorph-logo-jpg.jpg https://www.guyanahealthreview.com/article/905687330-haystack-health-appoints-digital-health-leader-bill-snyder-as-chief-executive-officer Guyana Health Review en PressRelease 2026-04-14T13:00:00+00:00 Haystack Health Appoints Digital Health Leader Bill Snyder as Chief Executive Officer https://ml.globenewswire.com/media/f6629b37-d06b-4203-a6cd-f233134c4f32/small/hh-logo-png.png https://www.guyanahealthreview.com/article/905687785-merakris-therapeutics-and-ifyber-collaboration-receives-top-sawc-research-award-for-mtx-001-wound-healing-study-in-human-skin-model Guyana Health Review en PressRelease 2026-04-14T13:00:00+00:00 Merakris Therapeutics and iFyber Collaboration Receives Top SAWC Research Award for MTX-001 Wound Healing Study in Human Skin Model https://ml.globenewswire.com/media/5b9c5fed-3332-4d4d-b8b6-6ab1b15faaed/small/mrks-brand-logo-final-fullcolor-png.png https://www.guyanahealthreview.com/article/905685907-just-salad-opens-in-east-amherst-n-y Guyana Health Review en PressRelease 2026-04-14T12:57:00+00:00 Just Salad Opens in East Amherst, N.Y. https://ml.globenewswire.com/media/0bfa206d-0a40-4b13-a05a-267ebef25a6a/medium/just-salad-east-amherst-new-york-storefront.jpg https://www.guyanahealthreview.com/article/905688308-entera-bio-to-host-key-opinion-leader-webinar-highlighting-the-osteoporosis-treatment-landscape-and-the-opportunity-for-eb613 Guyana Health Review en PressRelease 2026-04-14T12:45:00+00:00 Entera Bio to Host Key Opinion Leader Webinar Highlighting the Osteoporosis Treatment Landscape and the Opportunity for EB613 https://ml.globenewswire.com/media/9b4ae2bf-733d-4180-b48c-d0fa3f26c81a/small/logo-png.png https://www.guyanahealthreview.com/article/905688406-actuate-therapeutics-announces-nature-medicine-publication-of-clinical-trial-results-showing-doubling-of-the-rate-of-survival-with-elraglusib-plus Guyana Health Review en PressRelease 2026-04-14T12:45:00+00:00 Actuate Therapeutics Announces Nature Medicine Publication of Clinical Trial Results Showing Doubling of the Rate of Survival with Elraglusib Plus Chemotherapy in Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma https://ml.globenewswire.com/media/f65ca94c-eff8-4376-ac67-ded1b03b3bcc/small/actuatetx-logo-color300-jpg.jpg https://www.guyanahealthreview.com/article/905688494-extendicare-announces-closing-of-450-million-inaugural-offering-of-investment-grade-senior-unsecured-notes Guyana Health Review en PressRelease 2026-04-14T12:39:06+00:00 Extendicare Announces Closing of $450 Million Inaugural Offering of Investment Grade Senior Unsecured Notes https://ml.globenewswire.com/media/6d631964-eede-4e2c-912c-58ab7d1dc35f/small/extendicare-jpg.jpg https://www.guyanahealthreview.com/article/905686858-cellectar-enrolls-first-patient-in-clr-125-auger-emitting-radioconjugate-phase-1b-clinical-trial-targeting-refractory-triple-negative-breast-cancer Guyana Health Review en PressRelease 2026-04-14T12:35:00+00:00 Cellectar Enrolls First Patient in CLR 125 Auger-Emitting Radioconjugate Phase 1b Clinical Trial Targeting Refractory Triple Negative Breast Cancer (TNBC) https://ml.globenewswire.com/media/980abc5d-826f-4ac3-ad81-f07d69b34af6/small/cellectar-logo-1-jpg.jpg https://www.guyanahealthreview.com/article/905686003-pelthos-therapeutics-to-participate-in-piper-sandler-spring-biopharma-symposium Guyana Health Review en PressRelease 2026-04-14T12:30:00+00:00 Pelthos Therapeutics to Participate in Piper Sandler Spring Biopharma Symposium https://ml.globenewswire.com/media/7d71f2d0-a48f-4fe0-a49c-138de21bc0e1/small/pelthos-logo-rgb-png.png https://www.guyanahealthreview.com/article/905686896-cytodyn-to-present-at-the-aacr-annual-meeting-2026 Guyana Health Review en PressRelease 2026-04-14T12:30:00+00:00 CytoDyn to Present at the AACR Annual Meeting 2026 https://ml.globenewswire.com/media/3b426b4d-6299-4c23-9f95-058174a5b7be/small/new-logo-png.png https://www.guyanahealthreview.com/article/905687404-clinical-data-supporting-targeted-chemotherapeutic-delivery-via-renovorx-s-tamp-therapy-platform-presented-at-2026-sir-annual-scientific-meeting Guyana Health Review en PressRelease 2026-04-14T12:30:00+00:00 Clinical Data Supporting Targeted Chemotherapeutic Delivery via RenovoRx’s TAMP™ Therapy Platform Presented at 2026 SIR Annual Scientific Meeting https://ml.globenewswire.com/media/e18bf823-ff44-4bbd-82b9-3a311d58dad8/small/final-logo-horizontal-png.png https://www.guyanahealthreview.com/article/905688178-join-nexalin-s-exclusive-live-investor-webinar-and-q-a-session-on-april-21 Guyana Health Review en PressRelease 2026-04-14T12:30:00+00:00 Join Nexalin’s Exclusive Live Investor Webinar and Q&A Session on April 21 https://ml.globenewswire.com/media/7f481b55-16b6-4c8a-8356-30d54079a605/small/nexalin-jpg.jpg https://www.guyanahealthreview.com/article/905688250-meiragtx-to-present-3-year-data-from-the-phase-1-aquax-clinical-study-of-aav-haqp1-for-the-treatment-of-grade-2-3-radiation-induced-xerostomia-on Guyana Health Review en PressRelease 2026-04-14T12:30:00+00:00 MeiraGTx to Present 3-Year Data from the Phase 1 AQUAx Clinical Study of AAV-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia on Thursday, April 16, 2026 https://ml.globenewswire.com/media/6b45b8d0-975e-494b-8a46-b88360aa1791/small/mgx-logo-png.png https://www.guyanahealthreview.com/article/905688290-tomi-reports-strong-q1-2026-sales-of-high-margin-bit-solution-indicating-positive-growth-trends Guyana Health Review en PressRelease 2026-04-14T12:30:00+00:00 TOMI Reports Strong Q1 2026 Sales of High-Margin BIT Solution, Indicating Positive Growth Trends https://ml.globenewswire.com/media/f8c7c513-0121-4507-84b7-3680626d9cf3/small/tomi-jpg.jpg https://www.guyanahealthreview.com/article/905687539-biomerica-launches-infoods-ibs-in-canada-through-partnerships-with-phoenix-airmid-biomedical-and-canalt-health-labs Guyana Health Review en PressRelease 2026-04-14T12:19:00+00:00 Biomerica Launches inFoods® IBS in Canada Through Partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs https://ml.globenewswire.com/media/3461b9f0-3e95-484f-96e9-71608fc20239/small/biomerica-png.png https://www.guyanahealthreview.com/article/905673841-inspira-technologies-appoints-yoav-rozanovich-as-chief-business-officer-to-drive-immediate-revenue-growth-and-quantum-expansion Guyana Health Review en PressRelease 2026-04-14T12:01:00+00:00 Inspira Technologies Appoints Yoav Rozanovich as Chief Business Officer to Drive Immediate Revenue Growth and Quantum Expansion https://ml.globenewswire.com/media/6a4eabfe-c9ec-40d1-87fc-6f0d8e6e408c/small/screenshot-2025-04-02-at-19-21-06-png.png https://www.guyanahealthreview.com/article/905669423-community-routes-access-to-mental-health-care-provides-continued-funding-for-mental-health-services-at-free-charitable-clinics Guyana Health Review en PressRelease 2026-04-14T12:00:00+00:00 Community Routes: Access to Mental Health Care Provides Continued Funding for Mental Health Services at Free & Charitable Clinics https://ml-eu.globenewswire.com/media/c2001734-949b-4cc2-8021-b4b64eda1f13/small/teva-rgb-jpeg-jpg.jpg https://www.guyanahealthreview.com/article/905669681-amneal-launches-first-two-respiratory-metered-dose-inhalation-products-in-the-u-s Guyana Health Review en PressRelease 2026-04-14T12:00:00+00:00 Amneal Launches First Two Respiratory Metered-Dose Inhalation Products in the U.S. https://ml.globenewswire.com/media/a20d6f40-90af-422f-ab14-47208fdbad2f/small/amneal-rgb-k-png.png https://www.guyanahealthreview.com/article/905669769-biovie-announces-abstract-accepted-for-presentation-at-the-2026-american-academy-of-neurology-annual-meeting Guyana Health Review en PressRelease 2026-04-14T12:00:00+00:00 BioVie Announces Abstract Accepted for Presentation at the 2026 American Academy of Neurology Annual Meeting https://ml.globenewswire.com/media/f437d04b-c089-46eb-bca8-7ef64f68bc9b/small/biovie-logo-jpg.jpg https://www.guyanahealthreview.com/article/905669779-grace-therapeutics-announces-abstract-highlighting-strive-on-phase-3-trial-results-accepted-for-presentation-at-aan-2026 Guyana Health Review en PressRelease 2026-04-14T12:00:00+00:00 Grace Therapeutics Announces Abstract Highlighting STRIVE-ON Phase 3 Trial Results Accepted for Presentation at AAN 2026 https://ml.globenewswire.com/media/c71c0a95-caed-4520-87a9-ac7fefef3f07/small/grce-logo-jpg.jpg https://www.guyanahealthreview.com/article/905670492-er-kim-signs-exclusive-distribution-agreement-with-leo-pharma-a-s-to-commercialize-loqtorzi-toripalimab-for-nasopharyngeal-and-oesophageal-cancers Guyana Health Review en PressRelease 2026-04-14T12:00:00+00:00 Er-Kim Signs Exclusive Distribution Agreement with LEO Pharma A/S to Commercialize LOQTORZI® (toripalimab) for Nasopharyngeal and Oesophageal Cancers https://ml.globenewswire.com/media/37d25207-4dc0-4c58-b0cc-d589d363d644/small/erkim-logo-jpg.jpg https://www.guyanahealthreview.com/article/905670506-hinge-bio-announces-first-subject-dosed-in-phase-1-trial-of-hb2198-a-novel-b-cell-depleting-agent-for-treating-autoimmune-disease Guyana Health Review en PressRelease 2026-04-14T12:00:00+00:00 Hinge Bio Announces First Subject Dosed in Phase 1 Trial of HB2198, a Novel B cell Depleting Agent, for Treating Autoimmune Disease https://ml.globenewswire.com/media/62e1a1c6-154c-4dec-bfb4-79d43b015626/small/hinge-logo-color-2021-jpg.jpg https://www.guyanahealthreview.com/article/905671256-genecentric-to-present-data-on-fragmentomics-based-expressct-liquid-biopsy-technology-at-aacr-2026 Guyana Health Review en PressRelease 2026-04-14T12:00:00+00:00 GeneCentric to Present Data on Fragmentomics-Based ExpressCT™ Liquid Biopsy Technology at AACR 2026 https://ml.globenewswire.com/media/90d634f2-8dea-4f53-805f-e1e0eaa71133/small/genecentric-logo-jpg.jpg https://www.guyanahealthreview.com/article/905671300-rivus-pharmaceuticals-announces-first-patients-dosed-in-amplify-phase-2-trial-for-hu6-in-mash Guyana Health Review en PressRelease 2026-04-14T12:00:00+00:00 Rivus Pharmaceuticals Announces First Patients Dosed in AMPLIFY Phase 2 Trial for HU6 in MASH https://ml.globenewswire.com/media/b85bbdee-9fda-4cf2-a14f-d2d608f0b949/small/rivus-pharmaceuticals-logo-png.png https://www.guyanahealthreview.com/article/905671534-carlsmed-inc-to-report-first-quarter-2026-financial-results-on-may-5-2026 Guyana Health Review en PressRelease 2026-04-14T12:00:00+00:00 Carlsmed Inc. to Report First Quarter 2026 Financial Results on May 5, 2026 https://ml.globenewswire.com/media/ee16eff2-e0d6-40ca-95c5-4dd84bb4cc5f/small/carlsmed-png.png https://www.guyanahealthreview.com/article/905671584-nanox-announces-collaboration-with-meir-medical-center-to-deploy-nanox-arc-for-orthopedic-imaging-clinical-study Guyana Health Review en PressRelease 2026-04-14T12:00:00+00:00 Nanox Announces Collaboration with Meir Medical Center to Deploy Nanox.ARC for Orthopedic Imaging Clinical Study https://ml.globenewswire.com/media/57c1ffd6-84b3-46b9-b9b3-76666e6ba5a2/small/nano-logo-002-jpg.jpg https://www.guyanahealthreview.com/article/905672627-corbus-pharmaceuticals-announces-last-patient-first-visit-in-canyon-1-study-of-crb-913-for-the-treatment-for-obesity Guyana Health Review en PressRelease 2026-04-14T12:00:00+00:00 Corbus Pharmaceuticals Announces Last Patient First Visit in CANYON-1 Study of CRB-913 for the Treatment for Obesity https://ml.globenewswire.com/media/459d6fb1-b336-4d47-8aa1-f9198bda891d/small/corbus-logo-jpg.jpg https://www.guyanahealthreview.com/article/905672678-tempest-appoints-andrew-fang-ph-d-as-head-of-business-development-to-advance-strategic-partnerships-and-global-licensing-efforts Guyana Health Review en PressRelease 2026-04-14T12:00:00+00:00 Tempest Appoints Andrew Fang, Ph.D., as Head of Business Development to Advance Strategic Partnerships and Global Licensing Efforts https://ml.globenewswire.com/media/6ddb04fb-e5ac-416b-b90b-b4cbf51dc538/small/blue-logo-stacked-jpg.jpg https://www.guyanahealthreview.com/article/905672686-genvor-announces-strategic-memorandum-of-understanding-with-canlab-international-to-advance-commercial-peptide-pipeline Guyana Health Review en PressRelease 2026-04-14T12:00:00+00:00 Genvor Announces Strategic Memorandum of Understanding with Canlab International™ to Advance Commercial Peptide Pipeline https://ml.globenewswire.com/media/8533fef9-aa8f-43c5-9088-39ab06147641/small/43464-png.png https://www.guyanahealthreview.com/article/905672832-real-world-evidence-and-industry-momentum-builds-for-imdx-s-flagship-graftassure-assay Guyana Health Review en PressRelease 2026-04-14T12:00:00+00:00 Real-World Evidence and Industry Momentum Builds for iMDx’s Flagship GraftAssure Assay https://ml.globenewswire.com/media/418fe8d1-a6a4-4025-84ba-56f14ee83865/small/imdx-logo-png.png https://www.guyanahealthreview.com/article/905673675-calidi-biotherapeutics-announces-speaker-presentation-at-iovc-conference-in-reykjav-k-iceland-on-april-28th-highlighting-the-redtail-platform-s Guyana Health Review en PressRelease 2026-04-14T12:00:00+00:00 Calidi Biotherapeutics Announces Speaker Presentation at IOVC Conference in Reykjavík, Iceland on April 28th Highlighting the RedTail Platform’s Ability to Deliver Genetic Medicines to Distal Sites of Disease with Systemic Therapy https://ml.globenewswire.com/media/9e574b79-be62-4805-a4b4-cb0b7dcc5fbd/small/calidibiotherapeutics-logo-2x-jpg.jpg https://www.guyanahealthreview.com/article/905674131-aclarion-receives-pinnacle-award-for-ai-innovation Guyana Health Review en PressRelease 2026-04-14T12:00:00+00:00 Aclarion Receives Pinnacle Award for AI Innovation https://ml.globenewswire.com/media/6650177f-80b7-4c94-afb4-fc63aa3ada98/small/logo-png.png https://www.guyanahealthreview.com/article/905674226-r1-announces-revenue-performance-solutions-powered-by-phare-os-to-help-providers-navigate-growing-complexity-and-margin-pressure Guyana Health Review en PressRelease 2026-04-14T12:00:00+00:00 R1 Announces Revenue Performance Solutions Powered by Phare OS to Help Providers Navigate Growing Complexity and Margin Pressure https://ml.globenewswire.com/media/728189a4-e254-443f-8452-315403fd70f4/small/r1-logo-black-25-947x676-jpg.jpg https://www.guyanahealthreview.com/article/905674385-prenetics-im8-health-partners-with-vitamin-angels-to-combat-global-malnutrition-commits-to-impacting-400-000-mothers-and-children-in-year-one Guyana Health Review en PressRelease 2026-04-14T12:00:00+00:00 Prenetics’ IM8 Health Partners with Vitamin Angels to Combat Global Malnutrition, Commits to Impacting 400,000 Mothers and Children in Year One https://ml.globenewswire.com/media/106dbe1a-a6e1-49d9-97a2-c5609258bdc7/small/pre-logo-2026-png.png https://www.guyanahealthreview.com/article/905674450-clairity-announces-update-to-nccn-guidelines-to-include-ai-mammogram-based-risk-tool-to-identify-future-breast-cancer-risk-in-women-missed-by Guyana Health Review en PressRelease 2026-04-14T12:00:00+00:00 Clairity Announces Update to NCCN Guidelines to Include AI Mammogram-Based Risk Tool to Identify Future Breast Cancer Risk in Women Missed by Traditional Methods https://ml.globenewswire.com/media/0087b812-cef6-4183-8b7c-093385f3bcb5/small/clairitylogo-fullcolor-vertical-rgb-png.png https://www.guyanahealthreview.com/article/905671949-avita-medical-announces-positive-interim-results-from-cohealyx-study-demonstrating-accelerated-time-to-skin-grafting Guyana Health Review en PressRelease 2026-04-14T11:45:00+00:00 AVITA Medical Announces Positive Interim Results from Cohealyx® Study Demonstrating Accelerated Time to Skin Grafting https://ml.globenewswire.com/media/53ad8139-952a-4470-9ede-2f3bf0521f16/small/avita-png.png https://www.guyanahealthreview.com/article/905674267-clearmind-medicine-s-cmnd-100-meets-primary-endpoint-in-fda-approved-phase-i-iia-clinical-trial-for-alcohol-use-disorder Guyana Health Review en PressRelease 2026-04-14T11:32:00+00:00 Clearmind Medicine’s CMND-100 Meets Primary Endpoint in FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder https://ml.globenewswire.com/media/bd17cbf4-8124-4f86-8a4c-1fafbb6785af/small/logo-jpg.jpg https://www.guyanahealthreview.com/article/905670306-sanara-medtech-inc-to-report-first-quarter-2026-financial-results-on-may-12-2026 Guyana Health Review en PressRelease 2026-04-14T11:30:00+00:00 Sanara MedTech Inc. to Report First Quarter 2026 Financial Results on May 12, 2026 https://ml.globenewswire.com/media/591eb30b-d3e4-428c-9cd6-536215925b01/small/logo-jpg.jpg https://www.guyanahealthreview.com/article/905671016-profound-medical-to-participate-in-the-2026-bloom-burton-co-healthcare-investor-conference Guyana Health Review en PressRelease 2026-04-14T11:30:00+00:00 Profound Medical to Participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference https://ml.globenewswire.com/media/94d9e057-9de3-430c-9a19-b41ff3e06a1e/small/profound-logo-cmyk-copy-jpg.jpg https://www.guyanahealthreview.com/article/905671585-praxis-precision-medicines-announces-fda-acceptance-of-new-drug-application-for-ulixacaltamide-hcl-in-patients-with-essential-tremor Guyana Health Review en PressRelease 2026-04-14T11:30:00+00:00 Praxis Precision Medicines Announces FDA Acceptance of New Drug Application for Ulixacaltamide HCl in Patients with Essential Tremor https://ml.globenewswire.com/media/bff1e728-30ed-46c6-81e1-8bbc795929c0/small/01-primarylogo-color-bluex-100-jpg.jpg https://www.guyanahealthreview.com/article/905672048-anavex-life-sciences-highlights-new-scientific-findings-on-shared-biology-between-autism-and-alzheimer-s-disease Guyana Health Review en PressRelease 2026-04-14T11:30:00+00:00 Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer’s Disease https://ml.globenewswire.com/media/1b0f858f-4f7f-4f50-b691-a25307283fb5/small/anavexlogor-transparent-3x-png.png https://www.guyanahealthreview.com/article/905674084-medicenna-to-present-at-the-2026-bloom-burton-co-healthcare-investor-conference Guyana Health Review en PressRelease 2026-04-14T11:30:00+00:00 Medicenna to Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference https://ml.globenewswire.com/media/1644a38b-bed9-4a76-96fa-d57dd028e650/small/medicenna-jpg.jpg https://www.guyanahealthreview.com/article/905674299-avacta-ceo-christina-coughlin-named-as-one-of-in-vivo-s-2026-rising-leaders Guyana Health Review en PressRelease 2026-04-14T11:26:11+00:00 Avacta CEO Christina Coughlin Named as One of In Vivo's 2026 Rising Leaders https://ml.globenewswire.com/media/63584766-21c6-42e8-944c-7103432b045b/small/avacta-logo-full-color-rgb-oct-2024-jpg.jpg https://www.guyanahealthreview.com/article/905669756-adagene-adds-industry-veteran-peter-lebowitz-to-scientific-and-strategic-advisory-board Guyana Health Review en PressRelease 2026-04-14T11:00:00+00:00 Adagene Adds Industry Veteran Peter Lebowitz to Scientific and Strategic Advisory Board https://ml.globenewswire.com/media/c377318b-edf7-42c0-8e7c-63a02bbe47b0/small/adagene-logo-gnw-png.png https://www.guyanahealthreview.com/article/905669823-trained-therapeutix-discovery-s-chief-scientific-officer-dr-mulder-honored-with-fellowship-at-the-american-institute-for-medical-and-biological Guyana Health Review en PressRelease 2026-04-14T11:00:00+00:00 Trained Therapeutix Discovery’s Chief Scientific Officer, Dr. Mulder, Honored with Fellowship at the American Institute for Medical and Biological Engineering (AIMBE) https://ml.globenewswire.com/media/5f6e0329-ec9c-4ab1-9659-d99b938cce16/small/trained-therapeutix-logo-png.png https://www.guyanahealthreview.com/article/905671051-shopify-to-announce-first-quarter-2026-financial-results-may-5-2026 Guyana Health Review en PressRelease 2026-04-14T11:00:00+00:00 Shopify to Announce First-Quarter 2026 Financial Results May 5, 2026 https://ml.globenewswire.com/media/28cdf29b-fa48-43e3-a710-ea3ab811a26c/small/shopify-logo-black-png.png https://www.guyanahealthreview.com/article/905671069-axogen-inc-to-report-first-quarter-2026-financial-results-on-april-28-2026 Guyana Health Review en PressRelease 2026-04-14T11:00:00+00:00 Axogen, Inc. to Report First Quarter 2026 Financial Results on April 28, 2026 https://ml.globenewswire.com/media/3e4ffe78-2e9a-4972-915e-28c8477c84c1/small/axogen-logo-jpg.jpg https://www.guyanahealthreview.com/article/905671091-vitalhub-announces-novari-health-referral-central-intake-implementation-in-ontario Guyana Health Review en PressRelease 2026-04-14T11:00:00+00:00 VitalHub Announces Novari Health Referral Central Intake Implementation in Ontario https://ml.globenewswire.com/media/fae8da93-7d5e-4eb4-9121-d724c8555bce/small/greylogo-png.png https://www.guyanahealthreview.com/article/905672083-evolveimmune-therapeutics-to-present-update-on-lead-asset-evolve104-and-new-data-for-evolve-t-cell-engager-platform-at-2026-aacr-annual-meeting Guyana Health Review en PressRelease 2026-04-14T11:00:00+00:00 EvolveImmune Therapeutics to Present Update on Lead Asset EVOLVE104 and New Data for EVOLVE T Cell Engager Platform at 2026 AACR Annual Meeting https://ml.globenewswire.com/media/43892ec0-88ad-4f85-b32e-7d049f9ed422/small/evolveimmune-png.png https://www.guyanahealthreview.com/article/905673210-ocular-therapeutix-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Guyana Health Review en PressRelease 2026-04-14T11:00:00+00:00 Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/20ee0f50-7288-4f81-8546-f2ad2050ddbf/small/ocul-logo-jpg.jpg https://www.guyanahealthreview.com/article/905673892-ligand-partner-travere-therapeutics-receives-full-fda-approval-for-filspari-sparsentan-in-fsgs Guyana Health Review en PressRelease 2026-04-14T11:00:00+00:00 Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan) in FSGS https://ml.globenewswire.com/media/1fe91aa2-494e-4b30-89e8-cad771bbaabf/small/new-ligand-logo-png.png https://www.guyanahealthreview.com/article/905674161-tiziana-life-sciences-announces-late-breaking-poster-accepted-for-presentation-at-the-7th-world-parkinson-congress Guyana Health Review en PressRelease 2026-04-14T11:00:00+00:00 Tiziana Life Sciences Announces Late Breaking Poster Accepted for Presentation at the 7th World Parkinson Congress https://ml.globenewswire.com/media/991c340c-a083-4bcb-ad41-e7eea83f6f97/small/tiziana-logo-png.png https://www.guyanahealthreview.com/article/905658105-genmab-announces-net-sales-of-darzalex-daratumumab-for-first-quarter-of-2026 Guyana Health Review en PressRelease 2026-04-14T10:22:57+00:00 Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2026 https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg https://www.guyanahealthreview.com/article/905658895-ataibeckley-to-participate-in-upcoming-needham-healthcare-conferences Guyana Health Review en PressRelease 2026-04-14T10:00:00+00:00 AtaiBeckley to Participate in Upcoming Needham Healthcare Conferences https://ml.globenewswire.com/media/cea08bf4-0562-45ed-af5c-c9376c48a6eb/small/ataibeckley-horizontal-2color-png.png https://www.guyanahealthreview.com/article/905659602-greenwich-lifesciences-provides-update-on-financing-strategy Guyana Health Review en PressRelease 2026-04-14T10:00:00+00:00 Greenwich LifeSciences Provides Update on Financing Strategy https://ml.globenewswire.com/media/e0bfd967-b05f-43d2-91b4-d2a5d551df99/small/logo-edited-jpg.jpg https://www.guyanahealthreview.com/article/905647186-nxera-pharma-s-quviviq-daridorexant-25mg-and-50mg-receives-approval-in-taiwan-for-the-treatment-of-insomnia Guyana Health Review en PressRelease 2026-04-14T08:42:59+00:00 Nxera Pharma’s QUVIVIQ® (daridorexant) 25mg and 50mg Receives Approval in Taiwan for the Treatment of Insomnia https://ml-eu.globenewswire.com/media/5cc74d52-c86f-4e21-8684-3496281fee15/small/nxera-master-logo-rgb-black-1-png.png https://www.guyanahealthreview.com/article/905636102-mestag-therapeutics-selected-to-present-targeted-ltbr-agonist-mst-0312-in-late-breaking-session-at-aacr-annual-meeting Guyana Health Review en PressRelease 2026-04-14T07:30:00+00:00 Mestag Therapeutics Selected to Present Targeted LTBR Agonist MST‑0312 in Late‑Breaking Session at AACR Annual Meeting https://ml-eu.globenewswire.com/media/d47c1200-a3a8-42b0-b0b9-ffb74568b42c/small/mestag-tx-logo-png.png https://www.guyanahealthreview.com/article/905636143-asgard-therapeutics-appoints-professor-dr-wolfram-brugger-as-chief-medical-officer-as-it-advances-transformative-personalized-off-the-shelf Guyana Health Review en PressRelease 2026-04-14T07:30:00+00:00 Asgard Therapeutics appoints Professor Dr Wolfram Brugger as Chief Medical Officer as it advances transformative ‘personalized off-the-shelf’ immunotherapy toward clinical development https://ml-eu.globenewswire.com/media/5afbd1fa-9d4b-48d2-8f4f-d262d5a69053/small/asgard-tx-rgb-png.png https://www.guyanahealthreview.com/article/905614729-panntherapi-annonce-des-avanc-es-majeures-dans-son-d-veloppement-clinique-et-strat-gique Guyana Health Review en PressRelease 2026-04-14T06:00:00+00:00 PannTheraPi annonce des avancées majeures dans son développement clinique et stratégique https://ml-eu.globenewswire.com/media/79af9499-0fbe-4979-88f5-7c607773acb4/small/ https://www.guyanahealthreview.com/article/905614774-renaissance-pharma-limited-an-essential-pharma-company-secures-fda-fast-track-designation-and-ind-clearance-for-daretabart-hu1418k322a-in Guyana Health Review en PressRelease 2026-04-14T06:00:00+00:00 Renaissance Pharma Limited, an Essential Pharma company, secures FDA Fast Track Designation and IND clearance for Daretabart (hu1418K322A) in high-risk neuroblastoma https://ml-eu.globenewswire.com/media/31276511-f379-4a7a-90b6-af9fc9ac2aa0/small/66795319ca361c8d044a2cc6-essential-pharma-master-logo-png.png https://www.guyanahealthreview.com/article/905614817-panntherapi-announces-significant-clinical-development-and-strategic-milestones Guyana Health Review en PressRelease 2026-04-14T06:00:00+00:00 PannTheraPi Announces Significant Clinical Development and Strategic Milestones https://ml-eu.globenewswire.com/media/79af9499-0fbe-4979-88f5-7c607773acb4/small/logo-png.png https://www.guyanahealthreview.com/article/905614845-kuros-biosciences-reports-51-year-over-year-increase-in-sales-in-the-first-three-months-of-2026 Guyana Health Review en PressRelease 2026-04-14T05:00:00+00:00 Kuros Biosciences reports 51% year-over-year increase in sales in the first three months of 2026 https://ml-eu.globenewswire.com/media/ad3777c9-af1f-4b09-a899-3b3d6b8e962d/small/kuros-logo-jpg.jpg https://www.guyanahealthreview.com/article/905593433-rapid-nutrition-strengthens-capital-markets-infrastructure-with-appointment-of-bowsprit-partners Guyana Health Review en PressRelease 2026-04-14T03:00:00+00:00 Rapid Nutrition Strengthens Capital Markets Infrastructure with Appointment of Bowsprit Partners https://ml-eu.globenewswire.com/media/f5152816-94d7-4584-a49f-05ae66a44bf0/small/rapid-jpg.jpg https://www.guyanahealthreview.com/article/905574910-elite-force-xl-male-enhancement-gummies-claims-evaluated-effective-men-s-formula-for-steel-power-support Guyana Health Review en PressRelease 2026-04-14T01:36:27+00:00 Elite Force XL Male Enhancement Gummies Claims Evaluated: Effective Men's Formula for Steel Power Support https://zingfast.com/wp-content/uploads/2026/04/Elite-Force-XL-Male-Enhancement-Gummies.jpg https://www.guyanahealthreview.com/article/905574767-vital-step-glp-1-claims-evaluated-trusted-doctor-prescribed-glp-1-weight-loss-medication-with-no-hidden-fees Guyana Health Review en PressRelease 2026-04-14T01:11:21+00:00 Vital Step GLP-1 Claims Evaluated: Trusted Doctor-Prescribed GLP-1 Weight Loss Medication with No Hidden Fees https://zingfast.com/wp-content/uploads/2026/04/Vital-Step-GLP-1.jpg https://www.guyanahealthreview.com/article/905565700-gloramd-face-lift-serum-claims-evaluated-liquid-anti-aging-wrinkle-serum-solution-for-skin-renewal Guyana Health Review en PressRelease 2026-04-14T00:16:02+00:00 GloraMD Face Lift Serum Claims Evaluated: Liquid Anti-Aging Wrinkle Serum Solution for Skin Renewal https://zingfast.com/wp-content/uploads/2026/04/GloraMD-Face-Lift-Serum.jpg https://www.guyanahealthreview.com/article/905557661-biomerica-reports-third-quarter-fiscal-2026-financial-results Guyana Health Review en PressRelease 2026-04-13T22:57:27+00:00 Biomerica Reports Third Quarter Fiscal 2026 Financial Results https://ml.globenewswire.com/media/3461b9f0-3e95-484f-96e9-71608fc20239/small/biomerica-png.png https://www.guyanahealthreview.com/article/905557520-clean-eye-claims-evaluated-the-cleaneye-vision-care-capsules-for-retina-clear-visual-support Guyana Health Review en PressRelease 2026-04-13T22:46:54+00:00 Clean Eye Claims Evaluated: The CleanEye Vision Care Capsules for Retina Clear Visual Support https://zingfast.com/wp-content/uploads/2026/04/Clean-Eye.jpg https://www.guyanahealthreview.com/article/905549775-ballad-health-s-program-for-assisting-uninsured-patients-earns-national-award-for-its-community-based-approach-to-serving-rural-appalachia Guyana Health Review en PressRelease 2026-04-13T22:06:57+00:00 Ballad Health’s program for assisting uninsured patients earns national award for its community-based approach to serving rural Appalachia https://ml.globenewswire.com/media/MWQ0YWI3MDEtY2Q2Mi00NDk0LTk5MDAtNTEwNTEyYzRjY2Y5LTExMzUxNTItMjAyNi0wNC0xMy1lbg==/tiny/Ballad-Health.png https://www.guyanahealthreview.com/article/905549588-aim-immunotech-provides-routine-update-on-annual-filings Guyana Health Review en PressRelease 2026-04-13T22:00:00+00:00 AIM ImmunoTech Provides Routine Update on Annual Filings https://ml.globenewswire.com/media/8e85b83b-047f-4f99-9c51-1aa232ffe9bb/small/aimlogo-jpg.jpg https://www.guyanahealthreview.com/article/905542434-xortx-announces-closing-of-acquisition-of-vectus-kidney-anti-fibrotic-asset Guyana Health Review en PressRelease 2026-04-13T21:00:00+00:00 XORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset https://ml.globenewswire.com/media/9898c4f8-b373-438a-abfa-709c4372a061/small/xortx-logo-jpg.jpg https://www.guyanahealthreview.com/article/905542368-spyre-therapeutics-announces-proposed-public-offering-of-its-common-stock Guyana Health Review en PressRelease 2026-04-13T20:46:48+00:00 Spyre Therapeutics Announces Proposed Public Offering of its Common Stock https://ml.globenewswire.com/media/bc26a912-b583-43c6-8423-55a4ba2bf4bd/small/spyre-logo-horizontal-full-color-rgb-583px-300ppi-jpg.jpg https://www.guyanahealthreview.com/article/905535759-immucell-bolsters-its-innovation-strategy-with-appointments-of-dr-gilles-guillemette-and-dr-anthony-dimarco-to-the-board-and-moves-to-a-smaller Guyana Health Review en PressRelease 2026-04-13T20:38:05+00:00 ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors https://ml.globenewswire.com/media/680330c2-368b-4abc-9429-878b0c9fb1a2/small/immucell-jpg.jpg https://www.guyanahealthreview.com/article/905535401-bioage-labs-to-present-at-25th-annual-needham-virtual-healthcare-conference Guyana Health Review en PressRelease 2026-04-13T20:30:00+00:00 BioAge Labs to Present at 25th Annual Needham Virtual Healthcare Conference https://ml.globenewswire.com/media/d6df9eb5-87f7-4e2e-b503-8a7d8651428e/small/bioage-dark-logo-white-bg-500x500-png.png https://www.guyanahealthreview.com/article/905535572-cema-cel-pivotal-trial-interim-data-highlight-strength-of-cellectis-allogeneic-car-t-platform Guyana Health Review en PressRelease 2026-04-13T20:30:00+00:00 Cema-Cel Pivotal Trial Interim Data Highlight Strength of Cellectis’ Allogeneic CAR-T Platform https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png https://www.guyanahealthreview.com/article/905535574-les-donn-es-interm-diaires-de-l-essai-pivot-testant-cema-cel-mettent-en-vidence-la-solidit-de-la-plateforme-car-t-allog-nique-de-cellectis Guyana Health Review en PressRelease 2026-04-13T20:30:00+00:00 Les données intermédiaires de l'essai pivot testant cema-cel mettent en évidence la solidité de la plateforme CAR-T allogénique de Cellectis https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png